Search research articles
Contact Us
Filters
Showing results (921-930 of 967) with videos related to
Page
of 97
Sort By:
Journal of the American Academy of Dermatology
|
October 6, 2018
More than keratitis, ichthyosis, and deafness: Multisystem effects of lethal GJB2 mutations
Evelyn Lilly, Christopher G Bunick, Alexander M Maley, et al.
Pathology
|
June 23, 2022
Molecular typing of enteroviruses: comparing 5'UTR, VP1 and whole genome sequencing methods
T Gulholm, M Yeang, I Nguyen, et al.
Cancer Chemotherapy and Pharmacology
|
August 9, 2025
NSABP FC-11: A phase II study of neratinib plus trastuzumab or neratinib plus cetuximab in patients with "quadruple wild-type" (KRAS/NRAS/BRAF/PIK3CA) metastatic colorectal cancer based on HER2 status: amplified, non-amplified (wild-type), or mutated
Tanner J Freeman, Thomas J George, Samuel A Jacobs, et al.
Nature Genetics
|
November 5, 2025
Epigenetically driven and early immune evasion in colorectal cancer evolution
Eszter Lakatos, Vinaya Gunasri, Luis Zapata, et al.
Biorxiv : the Preprint Server for Biology
|
February 26, 2024
Epigenome and early selection determine the tumour-immune evolutionary trajectory of colorectal cancer
Eszter Lakatos, Vinaya Gunasri, Luis Zapata, et al.
Scientific Reports
|
February 23, 2022
Microbotanical residues for the study of early hominin tools
Julio Mercader, George Belev, Pastory Bushozi, et al.
Nature Communications
|
April 28, 2022
Somatic whole genome dynamics of precancer in Barrett's esophagus reveals features associated with disease progression
Thomas G Paulson, Patricia C Galipeau, Kenji M Oman, et al.
Breast Cancer Research : BCR
|
April 22, 2024
NSABP FB-10: a phase Ib/II trial evaluating ado-trastuzumab emtansine (T-DM1) with neratinib in women with metastatic HER2-positive breast cancer
Samuel A Jacobs, Ying Wang, Jame Abraham, et al.
ACS Medicinal Chemistry Letters
|
March 19, 2021
Discovery of Imidazopyridines as Potent Inhibitors of Indoleamine 2,3-Dioxygenase 1 for Cancer Immunotherapy
Liping Zhang, Emily C Cherney, Xiao Zhu, et al.
Internal Medicine Journal
|
November 6, 2023
Nocardia species distribution and antimicrobial susceptibility within Australia
Aine O'Brien, Julie Hart, Ammie Higgins, et al.
Page
of 97
Search research articles
Search
Showing results (921-930 of 967) with videos related to
Sort By:
Page
of 97
Journal of the American Academy of Dermatology
|
October 6, 2018
More than keratitis, ichthyosis, and deafness: Multisystem effects of lethal GJB2 mutations
Evelyn Lilly, Christopher G Bunick, Alexander M Maley, et al.
Pathology
|
June 23, 2022
Molecular typing of enteroviruses: comparing 5'UTR, VP1 and whole genome sequencing methods
T Gulholm, M Yeang, I Nguyen, et al.
Cancer Chemotherapy and Pharmacology
|
August 9, 2025
NSABP FC-11: A phase II study of neratinib plus trastuzumab or neratinib plus cetuximab in patients with "quadruple wild-type" (KRAS/NRAS/BRAF/PIK3CA) metastatic colorectal cancer based on HER2 status: amplified, non-amplified (wild-type), or mutated
Tanner J Freeman, Thomas J George, Samuel A Jacobs, et al.
Nature Genetics
|
November 5, 2025
Epigenetically driven and early immune evasion in colorectal cancer evolution
Eszter Lakatos, Vinaya Gunasri, Luis Zapata, et al.
Biorxiv : the Preprint Server for Biology
|
February 26, 2024
Epigenome and early selection determine the tumour-immune evolutionary trajectory of colorectal cancer
Eszter Lakatos, Vinaya Gunasri, Luis Zapata, et al.
Scientific Reports
|
February 23, 2022
Microbotanical residues for the study of early hominin tools
Julio Mercader, George Belev, Pastory Bushozi, et al.
Nature Communications
|
April 28, 2022
Somatic whole genome dynamics of precancer in Barrett's esophagus reveals features associated with disease progression
Thomas G Paulson, Patricia C Galipeau, Kenji M Oman, et al.
Breast Cancer Research : BCR
|
April 22, 2024
NSABP FB-10: a phase Ib/II trial evaluating ado-trastuzumab emtansine (T-DM1) with neratinib in women with metastatic HER2-positive breast cancer
Samuel A Jacobs, Ying Wang, Jame Abraham, et al.
ACS Medicinal Chemistry Letters
|
March 19, 2021
Discovery of Imidazopyridines as Potent Inhibitors of Indoleamine 2,3-Dioxygenase 1 for Cancer Immunotherapy
Liping Zhang, Emily C Cherney, Xiao Zhu, et al.
Internal Medicine Journal
|
November 6, 2023
Nocardia species distribution and antimicrobial susceptibility within Australia
Aine O'Brien, Julie Hart, Ammie Higgins, et al.
Page
of 97